HHGC
XLRN

Hunting Hill Global Capital’s Acceleron Pharma XLRN Stock Holding History

Hunting Hill Global Capital’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,000
Closed -$4.3M – 124
2021
Q3 		$4.3M Buy
+25,000
New +$3.27M 1.28% 9

Hunting Hill Global Capital's XLRN Position: Q4 2021 in Review

Hunting Hill Global Capital sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 25,000 shares — an estimated $4.3M sold.

Hunting Hill Global Capital first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $4.3M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Hunting Hill Global Capital reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Hunting Hill Global Capital sold 25,000 Acceleron Pharma shares in Q4 2021, an estimated $4.3M.
  • Hunting Hill Global Capital first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Hunting Hill Global Capital's Acceleron Pharma position peaked at $4.3M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Hunting Hill Global Capital's 13F filing for Q4 2021, filed 14 Feb 2022.